Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. (Q51017508)

27 March 2018

title

Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. (English)

1 reference

27 March 2018

author name string

Mitzi L Murray

1

1 reference

27 March 2018

Felecia Cerrato

2

1 reference

27 March 2018

Robin L Bennett

3

1 reference

27 March 2018

Gail P Jarvik

4

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 December 2011

1 reference

27 March 2018

published in

Genetics in Medicine

1 reference

27 March 2018

volume

13

1 reference

27 March 2018

issue

12

1 reference

27 March 2018

page(s)

998-1005

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1097/gim.0b013e318226fc15

exact match

0 references

cites work

Meta-analysis of BRCA1 and BRCA2 penetrance

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Risk-reduction surgery decisions in high-risk women seen for genetic counseling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Time to decide about risk-reducing mastectomy: a case series of BRCA1/2 gene mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

PALB2 sequence variants in young South African breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Genetic Testing for Women Previously Diagnosed with Breast/Ovarian Cancer: Examining the Impact of BRCA1 and BRCA2 Mutation Searching

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Clinical Characteristics Affect the Impact of an Uninformative DNA Test Result: The Course of Worry and Distress Experienced by Women Who Apply for Genetic Testing for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

Impact of Genetic Testing for Breast–Ovarian Cancer Susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318226FC15

10.1097/GIM.0B013E318226FC15

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

Dimensions Publication ID

0 references

1 reference

27 March 2018